Revenue: RM46.1m (up 29% from FY 2022). Net loss: RM38.5m (loss narrowed by 19% from FY 2022). RM0.028 loss per share (improved from RM0.038 loss in FY 2022). Don't forget that there may still be ...

PETALING JAYA: Bioalpha Holdings Bhd has proposed a RM110mil reduction of its issued share capital as part of a house keeping exercise of its balance sheet. In a filing with Bursa Malaysia, Bioalpha ...

Bioalpha (BIOA) has delivered a -50.000% change over the past year, with a 52-week range between 0.005 and 0.045. What Is the Average Daily Trading Volume of Bioalpha (BIOA)? The average daily trading ...

PETALING JAYA: Bioalpha Holdings Bhd has completed its acquisition of China-based supply chain management services provider Guizhou Hongbo Supply Chain Co Ltd for RM12.85mil. In a filing with Bursa ...

Revenue: RM7.27m (down 74% from 3Q 2021). Net loss: RM6.89m (down from RM1.57m profit in 3Q 2021). RM0.005 loss per share (down from RM0.001 profit in 3Q 2021). We should say that we've discovered 4 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

KUALA LUMPUR, June 4 -- Bioalpha Holdings Bhd (Bioalpha) has proposed a private placement exercise to raise up to RM14.2 million for the expansion and improvement in its digitalisation of business. In ...

KUALA LUMPUR, July 22 -- Bioalpha Holdings Bhd’s wholly-owned subsidiary Bioalpha (HK) Ltd has entered into a partnership agreement (PA) with two Chinese companies to strengthen its presence in the ...

Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Bioalpha Holdings Berhad (2 are significant) you should be aware of. Have feedback on this article?

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Bioalpha has a price-to-earnings (P/E) ratio of -0.58 (TTM). This compares to an industry average of 18.537. What is Bioalpha’s price-to-sales ratio? The P/S ratio for Bioalpha is currently 5.469 (TTM ...